Latest news and references to SMP2 and the National Lung Matrix Trial.
- Description
- Flagship Cancer Research UK precision medicine trial highlights the need for a new approach in treating genomically complicated cancers
- Date:
- 27/07/2020
- Description
- World Conference on Lung Cancer 2019
- Date:
- 17/12/2019
- Description
- ECMC Announcement - SMP2 and NLMT programme updates
- Date:
- 20/11/2017
- Description
- In this post, Jane Hair, a biobanker who works at the biorepository unit in Glasgow, and is involved in the National Lung Matrix Trial, shares what her job involves.
- Date:
- 23/05/2017
- Description
- Over 1,800 patients have been screened through the Stratified Medicine Programme Phase 2 (SMP2), with the 100th patient being recruited to the National Lung Matrix Trial (NLMT) in November 2016.
- Date:
- 21/12/2016
- Description
- The National Lung Matrix Trial (NLMT) is the first UK trial to combine the development of a technology platform that screens for multiple genetic aberrations in tumours (provided by CRUK's SMP2) with testing of multiple novel genetic-marker-directed drugs.
- Date:
- 27/10/2016
- Description
- The National Lung Matrix Trial: translation the biology of stratification in advanced non-small cell lung cancer
- Date:
- 25/09/2016
- Description
- The National Lung Matrix Trial (NLMT) is a flagship trial in the UK, being the first to combine the development of a technology platform that screens for multiple genetic aberrations in tumours (provided by CRUK's Stratified Medicine Programme 2) with testing of multiple novel genetic-marker-directed drugs.
- Date:
- 11/08/2016
- Description
- The CRUK Stratified Medicine Programme Phase 2 (SMP2) is the national pre-screening study to the National Lung MATRIX Trial (NLMT).
- Date:
- 17/06/2016
- Description
- The National Lung Matrix Trial (NLMT) is a flagship precision medicine trial, funded by CRUK, and supported by the Stratified Medicine Programme Phase 2 (SMP2) screening platform. It is to our knowledge currently the largest precision medicine trial globally.
- Date:
- 05/04/2016